Majid Teymoori‐Rad

Majid Teymoori‐Rad

Auto-generated profile, based on publicly available information

Majid Teymoori‐Rad

Department of Virology, School of Public Health Tehran University of Medical Sciences Tehran Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2019 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
MTMajid Teymoori‐Rad
Majid Teymoori‐Rad
FSFazel Shokri
Fazel Shokri
VSVahid Salimi
Vahid Salimi
MMMahdi Marashi
Mahdi Marashi

28 August 2020 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
MTMajid Teymoori‐Rad
Majid Teymoori‐Rad
MMMahdi Marashi
Mahdi Marashi

3 November 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
MGMohadeseh Zarei Ghobadi
Mohadeseh Zarei Ghobadi
RERahman Emamzadeh
Rahman Emamzadeh
MTMajid Teymoori-Rad
Majid Teymoori-Rad
EAElaheh Afsaneh
Elaheh Afsaneh
Severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) is the causative virus of the pandemic coronavirus disease 2019 (COVID-19). Evaluating the immunological factors and other implicated processes underlying the progression of COVID-19 is essential for the recognition and then the design of efficacious therapies. Therefore, we analyzed RNAseq data obtained from PBMCs of the COVID-19 patients to explore coding and non-coding RNA diagnostic immunological panels. For this purpose, we integrated multiple RNAseq data and analyzed them overall as well as by considering the state of disease including severe and non-severe conditions. Afterward, we utilized a co-expressed-based machine learning procedure comprising weighted-gene co-expression analysis and differential expression gene as filter phase and recursive feature elimination-support vector machine as wrapper phase. This procedure led to the identification of two modules containing 5 and 84 genes which are mostly involved in cell dysregulation and innate immune suppression, respectively. Moreover, the role of vitamin D in regulating some classifiers was highlighted. Further analysis disclosed the role of discriminant miRNAs including miR-197-3p, miR-150-5p, miR-340-5p, miR-122-5p, miR-1307-3p, miR-34a-5p, miR-98-5p and their target genes comprising GAN, VWC2, TNFRSF6B, and CHST3 in the metabolic pathways. These classifiers differentiate the final fate of infection toward severe or non-severe COVID-19. The identified classifier genes and miRNAs may help in the proper design of therapeutic procedures considering their involvement in the immune and metabolic pathways.

26 July 2020 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
HNHaideh Namdari
Haideh Namdari
FRFarhad Rezaei
Farhad Rezaei
MTMajid Teymoori‐Rad
Majid Teymoori‐Rad
SMSahar Mortezagholi
Sahar Mortezagholi
ASAhmadreza Sadeghi
Ahmadreza Sadeghi
AAAbolfazl Akbari
Abolfazl Akbari